IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,448,358 | +3.9% | 230,343 | -6.0% | 0.01% | +10.0% |
| Q2 2023 | $10,051,611 | +16.2% | 244,982 | +1.2% | 0.01% | +11.1% |
| Q1 2023 | $8,651,617 | +24.3% | 242,071 | +31.3% | 0.01% | +28.6% |
| Q4 2022 | $6,961,086 | +1.8% | 184,302 | +19.1% | 0.01% | -12.5% |
| Q3 2022 | $6,841,000 | +23.4% | 154,698 | +3.3% | 0.01% | +33.3% |
| Q2 2022 | $5,543,000 | -17.1% | 149,721 | -17.1% | 0.01% | 0.0% |
| Q1 2022 | $6,690,000 | +24.4% | 180,626 | +2.2% | 0.01% | +100.0% |
| Q4 2021 | $5,379,000 | -12.2% | 176,767 | -3.2% | 0.00% | 0.0% |
| Q3 2021 | $6,126,000 | -3.5% | 182,662 | +14.7% | 0.00% | 0.0% |
| Q2 2021 | $6,350,000 | +6.2% | 159,185 | +19.7% | 0.00% | 0.0% |
| Q1 2021 | $5,979,000 | -27.0% | 132,994 | -8.2% | 0.00% | -25.0% |
| Q4 2020 | $8,191,000 | +2.7% | 144,888 | -13.8% | 0.00% | -20.0% |
| Q3 2020 | $7,972,000 | -23.2% | 168,043 | -4.6% | 0.01% | -28.6% |
| Q2 2020 | $10,382,000 | +63.1% | 176,087 | +30.8% | 0.01% | +40.0% |
| Q1 2020 | $6,365,000 | -16.7% | 134,631 | +6.5% | 0.01% | -16.7% |
| Q4 2019 | $7,637,000 | +19.3% | 126,433 | +18.3% | 0.01% | +20.0% |
| Q3 2019 | $6,403,000 | -63.3% | 106,875 | -60.7% | 0.01% | -66.7% |
| Q2 2019 | $17,469,000 | -50.4% | 271,797 | -37.4% | 0.02% | -53.1% |
| Q1 2019 | $35,253,000 | +7.5% | 434,319 | -28.4% | 0.03% | -8.6% |
| Q4 2018 | $32,808,000 | +14.3% | 606,878 | +9.1% | 0.04% | +34.6% |
| Q3 2018 | $28,705,000 | +25.9% | 556,496 | +1.7% | 0.03% | +18.2% |
| Q2 2018 | $22,797,000 | -31.5% | 547,066 | -27.5% | 0.02% | -29.0% |
| Q1 2018 | $33,273,000 | +35.2% | 754,811 | +54.3% | 0.03% | +40.9% |
| Q4 2017 | $24,604,000 | +38.3% | 489,139 | +39.4% | 0.02% | +22.2% |
| Q3 2017 | $17,788,000 | +25.8% | 350,864 | +26.3% | 0.02% | +28.6% |
| Q2 2017 | $14,137,000 | -8.7% | 277,898 | -27.8% | 0.01% | 0.0% |
| Q1 2017 | $15,483,000 | +50.6% | 385,145 | +79.2% | 0.01% | +40.0% |
| Q4 2016 | $10,283,000 | +3.8% | 214,953 | -20.5% | 0.01% | +11.1% |
| Q3 2016 | $9,909,000 | +25.5% | 270,457 | -20.2% | 0.01% | 0.0% |
| Q2 2016 | $7,897,000 | -48.3% | 339,044 | -10.1% | 0.01% | -50.0% |
| Q1 2016 | $15,279,000 | -27.7% | 377,278 | +10.6% | 0.02% | -25.0% |
| Q4 2015 | $21,124,000 | – | 341,101 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |